298 related articles for article (PubMed ID: 9922078)
1. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor in the treatment of acute myeloid leukemia and acute lymphoblastic leukemia.
Ohno R
Leuk Res; 1998 Dec; 22(12):1143-54. PubMed ID: 9922078
[TBL] [Abstract][Full Text] [Related]
2. Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision making.
Bennett CL; Stinson TJ; Laver JH; Bishop MR; Godwin JE; Tallman MS
Leuk Lymphoma; 2000 Mar; 37(1-2):65-70. PubMed ID: 10721770
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
Bruserud O; Foss B; Petersen H
Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
[TBL] [Abstract][Full Text] [Related]
5. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
Geller RB
J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
[TBL] [Abstract][Full Text] [Related]
6. Granulocytic colony-stimulating factors (G-CSF and GM-CSF) in the treatment of adult acute myeloid leukemia.
Dombret H; Toubert ME; Schlageter MH; Chomienne C; Degos L
Nouv Rev Fr Hematol (1978); 1991; 33(6):445-8. PubMed ID: 1726333
[TBL] [Abstract][Full Text] [Related]
7. Use of cytokines in the treatment of acute lymphoblastic leukemia.
Nemunaitis J
Leukemia; 1997 May; 11 Suppl 4():S36-7. PubMed ID: 9179281
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor (CSF), macrophage-CSF, granulocyte-macrophage CSF, interleukin-3, and interleukin-6 levels in sera from children undergoing blood stem cell autografts.
Kawano Y; Takaue Y; Saito S; Sato J; Shimizu T; Suzue T; Hirao A; Okamoto Y; Abe T; Watanabe T
Blood; 1993 Feb; 81(3):856-60. PubMed ID: 7679001
[TBL] [Abstract][Full Text] [Related]
9. A comparative review of colony-stimulating factors.
Nemunaitis J
Drugs; 1997 Nov; 54(5):709-29. PubMed ID: 9360058
[TBL] [Abstract][Full Text] [Related]
10. Intensive short term therapy with granulocyte-macrophage-colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia. GOELAMS Group.
Ifrah N; Witz F; Jouet JP; François S; Lamy T; Linassier C; Pignon B; Berthou C; Guyotat D; Cahn JY; Harousseau JL
Cancer; 1999 Oct; 86(8):1496-505. PubMed ID: 10526278
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
Sallerfors B; Olofsson T
Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
[TBL] [Abstract][Full Text] [Related]
12. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
[TBL] [Abstract][Full Text] [Related]
13. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.
Sasse EC; Sasse AD; Brandalise S; Clark OA; Richards S
Cochrane Database Syst Rev; 2005 Jul; (3):CD004139. PubMed ID: 16034921
[TBL] [Abstract][Full Text] [Related]
14. The role of myeloid growth factors in acute leukemia.
Wadleigh M; Stone RM
J Natl Compr Canc Netw; 2009 Jan; 7(1):84-91. PubMed ID: 19176208
[TBL] [Abstract][Full Text] [Related]
15. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia.
Gurion R; Belnik-Plitman Y; Gafter-Gvili A; Paul M; Vidal L; Ben-Bassat I; Shpilberg O; Raanani P
Cochrane Database Syst Rev; 2011 Sep; (9):CD008238. PubMed ID: 21901718
[TBL] [Abstract][Full Text] [Related]
16. Growth factors in the treatment of acute lymphoblastic leukemia.
Ottmann OG; Hoelzer D
Leuk Res; 1998 Dec; 22(12):1171-8. PubMed ID: 9922081
[TBL] [Abstract][Full Text] [Related]
17. Myeloid growth factors as anti-infective measures in children with leukemia and lymphoma.
Lehrnbecher T; Creutzig U
Expert Rev Hematol; 2009 Apr; 2(2):159-72. PubMed ID: 21083449
[TBL] [Abstract][Full Text] [Related]
18. The use of GM-CSF and G-CSF in the treatment of acute leukemias.
Harousseau JL; Wu D
Leuk Lymphoma; 1995 Aug; 18(5-6):405-12. PubMed ID: 8528046
[TBL] [Abstract][Full Text] [Related]
19. [Low-dose granulocyte colony-stimulating factor combined with granulocyte-macrophage colony-stimulating factor for mobilizing peripheral CD34+ hematopoietic progenitor cells].
Meng FY; Xu B; Sun J; Yang Y; Niu JN
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):1051-2. PubMed ID: 15447861
[TBL] [Abstract][Full Text] [Related]
20. Granulocytic colony-stimulating factors in the management of patients with acute myeloid leukemia.
Dombret H
Hematol Cell Ther; 1996 Jul; 38(3):231-40. PubMed ID: 8974786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]